"10.1371_journal.pone.0092608","plos one","2014-03-21T00:00:00Z","Ankur Sharma; Christine Huard; Cecile Vernochet; Daniel Ziemek; Kelly M Knowlton; Edyta Tyminski; Theresa Paradis; Ying Zhang; Jessica E C Jones; David von Schack; Christopher T Brown; Patrice M Milos; Anthony J Coyle; Frederic Tremblay; Robert V Martinez","Centers for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America; CVMED, Pfizer Inc., Cambridge, Massachusetts, United States of America; Computational Sciences Center of Emphasis, Pfizer Inc, Cambridge, Massachusetts, United States of America; BioTherapeutics Clinical Research, Pfizer Inc., Cambridge, Massachusetts, United States of America; Global BioTherapeutics Technologies, Pfizer Inc., Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: AS CV FT RM. Performed the experiments: AS CH KK ET CV JJ. Analyzed the data: AS CH TP YZ DZ. Contributed reagents/materials/analysis tools: DVS CB. Wrote the paper: AS RM. Provided critical feedback: PM AC.","This work was funded, supported and performed using Pfizer resources. All authors were employed by Pfizer Inc. during the course of this study. Co-author Patrice M. Milos is currently employed by Claritas Genomics and co-author Frederic Tremblay is currently employed by Ember Therapeutics. There is a patent associated with BMP6 protein: US 6207813 B1 (BMP-6 proteins). There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Ankur Sharma","AS",15,TRUE,4,6,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
